Introduction: Finger involvement is highly prevalent in rheumatoid arthritis, and when deformity affects these fingers through joint destruction, it can markedly impact the activities of daily living. Progress in pharmacotherapy has dramatically improved disease activity control, but residual synovitis may still continue to affect the fingers of many patients. We previously reported that deformities and dysfunction progresses in such cases. However, no apparent correlations have been established between disease progression and disease activity. We therefore investigated how disease activity affected progression of finger deformity and dysfunction over time.
Methods: Between 2009 and 2015, we analyzed 37 patients with 63 hands affected by rheumatoid arthritis available for follow-up. Swan-neck deformity of the fingers were classified according to Nalebuff’s type classification. Boutonnière deformity of the fingers were classified according to Nalebuff’s stage classification. Hand function and upper extremity function was assessed based on a modified Kapandji index (MKI) and Disabilities of the Arm, Shoulder and Hand (DASH) score. Changes in disease activity from 2009 through 2015 were used to divide the patients into the following four groups: “improved”, “low disease activity maintained”, “high disease activity maintained”, and a “worsening” group.
Results: There were 22, 9, 16, and 16 hands in the improved, low disease activity maintained, high disease activity maintained, and worsening groups, respectively. Finger deformities progressed in all four groups with a statistically significant worsening observed in all groups, except for the low disease activity maintained group. MKI was only maintained in the low disease activity maintained group. DASH improvement during the study period was only seen in the low disease activity maintained and improved groups, while marked worsening was noted in the high disease activity maintained group and worsening group.
Discussion: Goals in treating rheumatoid arthritis include clinical, structural, and functional remission, but until now, it has been unknown whether pharmacotherapy would be effective in achieving the latter two forms of remission. This study clarifies that although finger deformity does progress regardless of disease activity control, finger function can be maintained by keeping disease activity low over the long term. With the use of appropriate pharmacotherapy, it is possible to achieve these treatment goals.
Conclusion: Physicians who treat rheumatoid disease must continue their efforts in daily clinical practice to preserve finger function by suppressing disease activity to as low as possible.
View full abstract